These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35014746)

  • 21. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
    Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data.
    Aziz F; Aberer F; Bräuer A; Ciardi C; Clodi M; Fasching P; Karolyi M; Kautzky-Willer A; Klammer C; Malle O; Pawelka E; Pieber T; Peric S; Ress C; Schranz M; Sourij C; Stechemesser L; Stingl H; Stöcher H; Stulnig T; Tripolt N; Wagner M; Wolf P; Zitterl A; Reisinger AC; Siller-Matula J; Hummer M; Moser O; von-Lewinski D; Eller P; Kaser S; Sourij H
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.
    Singh AK; Singh R; Saboo B; Misra A
    Diabetes Metab Syndr; 2021; 15(1):159-167. PubMed ID: 33352455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.
    Christiansen C; Johansen M; Christensen S; O'Brien JM; Tønnesen E; Sørensen H
    Crit Care; 2013 Sep; 17(5):R192. PubMed ID: 24018017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 outcomes in patients taking cardioprotective medications.
    Morrison FJ; Su M; Turchin A
    PLoS One; 2022; 17(10):e0275787. PubMed ID: 36215288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
    Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
    Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
    Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
    Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
    Lukito AA; Pranata R; Henrina J; Lim MA; Lawrensia S; Suastika K
    Diabetes Metab Syndr; 2020; 14(6):2177-2183. PubMed ID: 33395778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
    Bramante CT; Ingraham NE; Murray TA; Marmor S; Hovertsen S; Gronski J; McNeil C; Feng R; Guzman G; Abdelwahab N; King S; Tamariz L; Meehan T; Pendleton KM; Benson B; Vojta D; Tignanelli CJ
    Lancet Healthy Longev; 2021 Jan; 2(1):e34-e41. PubMed ID: 33521772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching.
    Lohia P; Kapur S; Benjaram S; Cantor Z; Mahabadi N; Mir T; Badr MS
    Cardiovasc Diabetol; 2021 Jul; 20(1):140. PubMed ID: 34246277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity.
    Bramante CT; Buse J; Tamaritz L; Palacio A; Cohen K; Vojta D; Liebovitz D; Mitchell N; Nicklas J; Lingvay I; Clark JM; Aronne LJ; Anderson E; Usher M; Demmer R; Melton GB; Ingraham N; Tignanelli CJ
    J Med Virol; 2021 Jul; 93(7):4273-4279. PubMed ID: 33580540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
    Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
    World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study.
    He S; Qian X; Chen Y; Shen X; Zhang B; Chen X; Xu X; Li G
    J Diabetes Res; 2021; 2021():5534387. PubMed ID: 34222493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.
    Madsen KS; Kähler P; Kähler LKA; Madsbad S; Gnesin F; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012368. PubMed ID: 30998259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
    Tseng CH
    J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
    Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.
    Chen Y; Lv X; Lin S; Arshad M; Dai M
    Front Endocrinol (Lausanne); 2022; 13():895458. PubMed ID: 35692410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.